Armata Pharmaceuticals delays Q4 2025 earnings, gets FDA designation
Go back to Armata Pharmaceuticals delays Q4 2025 earnings, gets FDA designation| Aurum Resources Corp (NYSE: ARMP) | Delayed: 7.35 +0.34 (4.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.01 | 52 Week High | $2.00 | |||
| Open | $6.90 | 52 Week Low | $1.50 | |||
| Day High | $7.40 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $0.00 | |||
| Volume | 356,137 | |||||
